Search for: "Abbott Laboratories, The"
Results 1 - 20 of 255
Sorted by Relevance | Sort by Date
13 Mar, 2007 6:40 am
... substantive ruling in Abbott's appeal of a trial court's judgment and injunction in favor of Innogenetics. The court denied Abbott Laboratories' motion for a stay of injunction pending appeal. Following a January 10, 2007 ruling by the U.S. District Court for the Western
District of Wisconsin which permanently enjoined Abbott from any further sales, use or export of products, including components, that infringe
on Innogenetics' U.S. Patent No. 5,846,704 ...
28 Jul, 2008 11:59 am
... Federal Holds Plaintiffs filed a class action lawsuit against their former employer, Abbott Laboratories, and their new employer,
Hospira, a newly-created corporate entity, ... spun off HPD violated sections 510 and 404 of ERISA. Nauman v. Abbott Labs., ___ F.Supp.2d ___
(N.D.Ill. July ... Count I, coupled with the policies challenged in Counts II and III, constitute a 'scheme' that Abbott conceived, and that
the defendants jointly adopted, with the specific intent of avoiding the payment of projected ...
16 Jun, 2007 8:17 pm
... government filed a fraud action against Abbott Laboratories, Inc. in Massachusetts court on June 4, 2007. The government alleges
that over the past several years, Abbott has reported inflated pharmaceutical prices that it knew Medicare and Medicaid relied upon to set ...
's pharmaceutical products. Abbott's reported prices that were often 1000% higher than Abbott's
actual prices, ensuring that Abbott's customers received inflated reimbursements and profits from Medicare and ...
29 Oct, 2008 4:53 am
... in Abbott Laboratories v. Sandoz By Kevin E. Noonan --The Court of Appeals for the Federal Circuit affirmed grant of a preliminary
injunction in Abbott Laboratories v. Sandoz on October 21, and also affirmed the District Court's determination that the patents-in-suit
... coming to both conclusions, the majority decision illustrated nicely the appellate penchant (and prerogative) of deciding where lines are to be drawn when considering equitable
issues. Abbott's patents-in-suit, U.S. Patent Nos....
31 Oct, 2008 3:32 am
Opposing Federal Circuit Preliminary Injunction Standards in Abbott Laboratories v. Sandoz By Kevin E. Noonan -- The decision of the
Court of Appeals for the Federal Circuit in Abbott Laboratories v. Sandoz, affirming the District Court's grant of a preliminary
injunction, nicely illustrates the way the Federal Circuit exercises its prerogatives in applying the abuse of discretion standard. In our previous post, we discussed the portion of ...
20 Mar, 2008 7:26 pm
California, the District of Columbia, and seventeen other states have filed suit against Abbott Laboratories for allegedly entering into
a scheme to block the generic version of the cholesterol lowering drug TriCor, reported the East Bay ... attempted to monopolize the market for drugs containing the ingredient
fenofibrate, which regulates cholesterol and triglyceride levels. Abbott licenses from Fournier American rights to the drug and Solvay sells
the drug on the European market. . . . According ...
16 Sep, 2006 2:19 pm
On September 8, a unanimous jury found that Abbott Laboratories willfully infringed Innogenetics pattent (U.S. Patent No. 5,846,704) for
a method of genotyping the Hepatitis C Virus (HCV). Innogentics was awarded $7 million for the patent infringement and the company plans to seen an injunction against Abbott products that infringe the patent. PR Newswire Reports: "This is a landmark victory for Innogenetics, and possibly for other innovators like us out
there," said ...
8 Aug, 2008 2:44 am
Lawsuits filed in Oakland federal court claim that Abbott Laboratories Inc. raised the price of its AIDS drug Norvir by 400 percent in
an attempt to increase sales of its drug Kaletra and suppress competition. The company has settled one ... to be worth between $10 and $27.5 million. As reported by the Sacramento Bee,
"Executives acknowledged in 2003 internal memos that Abbott would appear as the "big, bad, greedy pharmaceutical company" if they implemented
the Norvir price hike, according to court ...
19 May 4:23 am
By Kevin E. Noonan -- In an otherwise unremarkable decision affirming the district court's claim construction and summary judgment of noninfringement in Abbott Laboratories v. Sandoz, Inc., the Court of Appeals for the Federal Circuit took the opportunity to reconcile a long-standing conflict in its
precedent. Deciding this portion en banc, the court expressly overruled its earlier panel decision in Scripps Clinic & ...
28 Jul 1:26 pm
Did you hear that on June 29th, a federal court jury in Texas returned a verdict in favor of Centocor Ortho Biotech Inc. in the amount of $1.67 billion against Abbott Laboratories. The case was a patent infringement suit. Centocor Ortho Biotech Inc. created when Ortho Biotech Inc. merged into Centocor, Inc.,
and Centocor, Inc. was renamed [...]
30 Jun 2:01 am
... with Abbott to join its direct competitor, Defendant ev3, Inc. She had an employment agreement with Abbott. The Employee Agreement allegedly prohibits Mancheski, for the period of one year following the termination of her employment with Abbott, from engaging in activities or employment (a) that contribute to the development, marketing, promotion or sale of products that compete with
Abbott products for which Mancheski previously had responsibility, or (b) in which she would use or divulge ...
14 Nov, 2006 2:10 pm
A Reference May Anticipate Even When the Relevant Properties of the Disclosure Were Not Appreciated at the Time. (Fed. Cir. 2006, 06-1021) Abbott appealed from a district court (N.D. Ill.) judgment of noninfringement of U.S. Patent No. 5,990,176 ("the '176 patent"). Baxter cross-appealed, arguing
that the asserted claims are invalid. In it's second hearing of this case, the CAFC [...]
1 Mar, 2007 4:22 pm
On February 2, 2007, the Seventh Circuit (Posner, J.) enforced a forum-selection clause favoring Takeda, a Japanese pharmaceutial company, and thus affirmed the District Court's
dismissal of Abbott Labs' suit brought in the Northern District of Illinois. The full opinion...
8 Jan 2:57 pm
... , said the case should be heard in Boston because some of its research and manufacturing of Humira is done at the company's Worcester facility. (Abbott Laboratories v. Bayer Healthcare LLC, 09cv40002, U.S. District Court for the District of Massachusetts). It could be that Abbott feels that Humira can be distinguished from the claims of the '407 patent since its antibodies are "humanized" monoclonal antibodies. However, it
appears that Humira ...
27 Feb, 2008 4:12 am
... California Federal Court Holds Plaintiff filed a putative class action against Abbott Laboratories in California state court on
September 25, 2007, and defense attorneys ... existed under the Class Action Fairness Act of 2005 (CAFA). Thorpe v. Abbott Laboratories,
Inc., ___ F.Supp.2d ___ (N.D. Cal ... allegations stricken, "because plaintiff's claims for unpaid overtime for Pharmaceutical Representatives at Abbott are based on the same facts and circumstances as those alleged in a parallel federal action ...
18 Mar, 2008 1:13 pm
... s opt-out model for wage-related claims in Thorpe v. Abbott Laboratories, Inc. In this case, former Abbott pharmaceutical representative Thorpe initiated a putative class action suit ... a great choice. You took a risk, but it was not your best performance,
Abbott Labs. It did have a lot of color. (Shut up and let me ... which was like bad karaoke or cruise ship cabaret." The court also rejected
Abbott's request to strike the class allegations, holding this was an argument more appropriately considered ...
16 Nov 1:07 pm
Centocor Ortho Biotech, Inc. v. Abbott Laboratories, 2009 WL 3734119(E.D.Tex. Nov 04, 2009) (NO. 2:07-CV-139- ... readers will recall,
this is the case where Centocor obtained a large infringement verdict against defendant Abbott Laboratories in late June of this year.
Judge Ward previously set aside the jury' ... responses, the applicable law, and explaining what he found, Judge Ward concluded that Abbott had
not satisfied its burden of proving that Centocor made material misrepresentations or omissions ...
18 Jan, 2008 2:34 pm
... of the 5′ untranslated region of the HCV. The district court granted Innogenetics' motion to exclude testimony on obviousness by Abbott's
witness, Dr. Patterson. However, the written order commemorating the conference rulings inaccurately stated that defendant ... Abbott infringed
Innogenetics' HCV genotyping patent or the jury's determination that Abbott must pay damages for its infringement. See Innogenetics v.
Abbott Laboratories, United States Court of Appeals for the Federal Circuit (07-1145). ...
10 Jan, 2007 8:56 pm
Abbott Laboratories is currently fighting antitrust allegations relating to two of its best-selling drugs: Norvir, a protease inhibitor
used in AIDS treatment, and Hytrin, a drug used to treat enlarged prostate and hypertension. ... sparked an investigation by the Illinois Attorney General's office, as well as federal
antitrust lawsuits. At the same time, Abbott is fighting allegations of unlawful monopolization in connection with Hytrin. Kaiser Foundation
Health Plan, a health care provider, is ...
12 Apr, 2007 7:00 am
After Abbott Laboratories announced that it would not launch new medicines in Thailand in response to the military-installed
government's decision not to honor the company's patent for its AIDS drug, the company ... the debate around pricing of HIV medicines: by increasing affordability while preserving the
system that enables the discovery of new medicines. Abbott and the WHO pointed out that patents must exist so that there are incentives for
sustained research and development. Without this system ...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog Search |
Technorati | Google | MSN | Yahoo!